pharma news

News

ADA: Vertex closer to weaning type 1 diabetics off insulin

A cell therapy developed by Vertex Pharma has allowed 10 of 12 patients with type 1 diabetes to control their blood sugar without insulin.

News

Novo Nordisk's fling with Hims & Hers ends in a bust-up

The alliance between Novo Nordisk and telehealth firm Hims & Hers for the distribution of GLP-1 agonist weight-loss therapies has ended in acrimony.

News

Senator says ACIP next meeting should be postponed

Republican Senator Bill Cassidy says tomorrow's meeting of the CDC's vaccines advisory committee should be delayed as the new members may be biased.

News

ASCO 25: Regeneron hails Libtayo's adjuvant data in CSCC

Regeneron's PD-1 inhibitor Libtayo hits the mark where MSD's Keytruda missed in a form of non-melanoma skin cancer.

News

NICE backs use of MSD's KEYTRUDA for triple-negative breast ...

For the first time, patients in England with triple-negative breast cancer (TNBC) will be able to access immunotherapy at an earlier stage of their treatment journey, as Merck & Co/MSD'

Events

Partner Content

IMPACCT:RWE - Real-World Evidence Conference, Boston 2018

Real-World Evidence Conference

ADA: Vertex closer to weaning type 1 diabetics off insulin

Novo Nordisk's fling with Hims & Hers ends in a bust-up

Senator says ACIP next meeting should be postponed

ASCO 25: Regeneron hails Libtayo's adjuvant data in CSCC

NICE backs use of MSD's KEYTRUDA for triple-negative breast ...

IMPACCT:RWE - Real-World Evidence Conference, Boston 2018

MSD takes a $400m bite of SciBrunch's KRAS drug

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks